Home / Recalls / Fresenius Kabi Compounding, LLC / D-0337-2026

D-0337-2026 Class II Ongoing

Recalled by Fresenius Kabi Compounding, LLC — Canton, MA

Recall Details

Product Type
Drugs
Report Date
February 18, 2026
Initiation Date
February 5, 2026
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Product Description

vancomycin HCl, 2 grams, 2 grams added to 500 mL, 0.9% Sodium Chloride Injection, USP, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-019-59.

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

US Nationwide.

Code Information

Lot # C274-000047611, Exp Date: 10-Feb-26; Lot # C274-000049633, Exp Date: 12-May-26.

Other recalls by Fresenius Kabi Compounding, LLC

  • D-0333-2026 Class II — acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, (February 5, 2026)
  • D-0335-2026 Class II — thiamine HCl, 500 mg, 500 mg added to 100 mL, 0.9% Sodium Chloride Injection, US (February 5, 2026)
  • D-0336-2026 Class II — vancomycin HCl, 1.5 grams, 1.5 grams added to 500 mL, 0.9% Sodium Chloride Injec (February 5, 2026)
  • D-0334-2026 Class II — ketamine HCl, 1,000 mg, 1,000 mg per 100 mL (10 mg per mL) in Sodium Chloride In (February 5, 2026)
  • D-0016-2025 Class II — Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 10 mg per 250 mL, Single D (September 25, 2024)
  • D-0020-2025 Class II — NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL, S (September 25, 2024)
  • D-0021-2025 Class II — Oxytocin 0.9% Sodium Chloride Injection USP, 30 units per 500 mL Single Dose Bag (September 25, 2024)
  • D-0019-2025 Class II — NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 4 mg per 250 mL, S (September 25, 2024)
  • D-0014-2025 Class II — Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single D (September 25, 2024)
  • D-0018-2025 Class II — Vancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USP, Single Dose (September 25, 2024)